Guardant Health (GH) Common Equity (2017 - 2026)
Guardant Health's Common Equity history spans 9 years, with the latest figure at -$99.3 million for Q4 2025.
- On a quarterly basis, Common Equity rose 28.89% to -$99.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$99.3 million, a 28.89% increase, with the full-year FY2025 number at -$99.3 million, up 28.89% from a year prior.
- Common Equity hit -$99.3 million in Q4 2025 for Guardant Health, up from -$354.5 million in the prior quarter.
- Over the last five years, Common Equity for GH hit a ceiling of $847.0 million in Q1 2021 and a floor of -$354.5 million in Q3 2025.
- Historically, Common Equity has averaged $178.0 million across 5 years, with a median of $113.5 million in 2023.
- Biggest five-year swings in Common Equity: soared 253.27% in 2024 and later crashed 18838.31% in 2025.
- Tracing GH's Common Equity over 5 years: stood at $645.0 million in 2021, then plummeted by 90.67% to $60.2 million in 2022, then soared by 163.68% to $158.7 million in 2023, then crashed by 188.0% to -$139.6 million in 2024, then rose by 28.89% to -$99.3 million in 2025.
- Business Quant data shows Common Equity for GH at -$99.3 million in Q4 2025, -$354.5 million in Q3 2025, and -$305.5 million in Q2 2025.